Chengdu Pilot Pharmaceutical Development Co., Ltd. shareholder inquiry and transfer results report and indicative notice on changes in equity of shareholders holding 5% or more of shares to reduce their holdings by 1%
China International Finance Corporation Verification Report on Shareholders of Chengdu Pilot Pharmaceutical Development Co., Ltd. requesting quotations and transfers of shares to specific institutional investors
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Chengdu Xiandao Pharmaceutical Development Co., Ltd.
Legal Opinion of Beijing Junhe (Chengdu) Law Firm on the 2023 Annual General Meeting of Shareholders of Chengdu Xiandao Pharmaceutical Development Co., Ltd.
Chengdu Pilot Pharmaceutical Development Co., Ltd. Shareholder Inquiry Transfer Pricing Information Suggestive Notice
Chengdu Pilot Pharmaceutical Development Co., Ltd. Shareholder Inquiry Transfer Plan
China International Finance Corporation's inspection opinions on the qualifications of shareholders of Chengdu Pilot Pharmaceutical Development Co., Ltd. to inquire and transfer shares from specific institutional investors
Investor Relations Activity Record Form (2023 and 2024 First Quarter Results Briefing)
China International Finance Corporation's sponsorship summary report on the initial public offering of shares of Chengdu Pilot Pharmaceutical Development Co., Ltd. and its listing on the Science and Technology Innovation Board
China International Finance Corporation's 2023 Continuous Supervision and Follow-up Report on Chengdu Pilot Drug Development Co., Ltd.
Announcement of Chengdu Pilot Pharmaceutical Development Co., Ltd. on the resignation of the company's supervisor
Chengdu Xiandao Pharmaceutical Development Co., Ltd. 2023 Annual General Meeting of Shareholders Meeting Materials
Announcement of Chengdu Pilot Pharmaceutical Development Co., Ltd. on holding a performance briefing for the first quarter of 2023 and 2024
China International Finance Corporation's 2023 Continuous Supervision Site Inspection Report on Chengdu Pilot Drug Development Co., Ltd.
“Read in one picture” Chengdu Pilot's 2023 Annual Report and 2024 Quarterly Report
Investor Relations Activity Schedule (April 25, 2024)
Chengdu Pilot Pharmaceutical Development Co., Ltd. Board Audit Committee Supervises Deloitte Huayong Certified Public Accountants (Special General Partnership) Performance Report
Chengdu Pilot Drug Development Co., Ltd. 2023 Independent Director Debriefing Report (Liu Zewu)
Chengdu Pilot Drug Development Co., Ltd. 2023 Independent Director Debriefing Report (Xue Junfu)
Chengdu Pilot Pharmaceutical Development Co., Ltd. 2023 Independent Director Debriefing Report (Yu Haizong)
No Data